These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9742221)

  • 1. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase.
    Russwurm M; Behrends S; Harteneck C; Koesling D
    Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):125-30. PubMed ID: 9742221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.
    Hoenicka M; Becker EM; Apeler H; Sirichoke T; Schröder H; Gerzer R; Stasch JP
    J Mol Med (Berl); 1999 Jan; 77(1):14-23. PubMed ID: 9930922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
    Bellamy TC; Garthwaite J
    Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human soluble guanylate cyclase: functional expression and revised isoenzyme family.
    Zabel U; Weeger M; La M; Schmidt HH
    Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):51-7. PubMed ID: 9742212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
    Schrammel A; Behrends S; Schmidt K; Koesling D; Mayer B
    Mol Pharmacol; 1996 Jul; 50(1):1-5. PubMed ID: 8700100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components.
    Martin E; Lee YC; Murad F
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12938-42. PubMed ID: 11687640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of soluble guanylate cyclase by ODQ.
    Zhao Y; Brandish PE; Di Valentin M; Schelvis JP; Babcock GT; Marletta MA
    Biochemistry; 2000 Sep; 39(35):10848-54. PubMed ID: 10978171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the soluble guanylyl cyclase alpha1/alpha2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus.
    De Backer O; Elinck E; Sips P; Buys E; Brouckaert P; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):493-502. PubMed ID: 18563392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
    Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoforms of NO-sensitive guanylyl cyclase.
    Russwurm M; Koesling D
    Mol Cell Biochem; 2002 Jan; 230(1-2):159-64. PubMed ID: 11952091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation.
    Faraci FM; Sobey CG
    Brain Res; 1999 Mar; 821(2):368-73. PubMed ID: 10064823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity.
    Sharina IG; Jelen F; Bogatenkova EP; Thomas A; Martin E; Murad F
    J Biol Chem; 2008 May; 283(22):15104-13. PubMed ID: 18381288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional domain of the alpha1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme binding.
    Koglin M; Behrends S
    J Biol Chem; 2003 Apr; 278(14):12590-7. PubMed ID: 12560334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of YC-1-induced activation of soluble guanylyl cyclase.
    Friebe A; Koesling D
    Mol Pharmacol; 1998 Jan; 53(1):123-7. PubMed ID: 9443939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the vasorelaxant effects of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft.
    Berkan O; Bagcivan I; Kaya T; Yildirim K; Yildirim S; Doğan K
    Can J Physiol Pharmacol; 2007 May; 85(5):521-6. PubMed ID: 17632587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate.
    Hussain AS; Marks GS; Brien JF; Nakatsu K
    Can J Physiol Pharmacol; 1997 Aug; 75(8):1034-7. PubMed ID: 9360020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.